| Literature DB >> 35246574 |
Koki Abe1, Hyonmin Choe2, Masatoshi Oba1, Taro Tezuka1, Hiroyuki Ike1, Naomi Kobayashi3, Yutaka Inaba1.
Abstract
Preoperative diagnosis of infection is important for appropriate surgical treatment of patients with rapid hip destruction (RHD). We investigated whether test results, including inflammatory and nutritional markers, could be used to accurately differentiate infectious and non-infectious RHD. Fifty patients with RHD who underwent total hip arthroplasty within a year of onset were observed. Infectious RHD was defined as ≥ 2 positive serological inflammatory, microbiological, or pathological evaluations. The albumin to globulin ratio (AGR), C-reactive protein (CRP)/albumin ratio (CAR), Glasgow prognostic score (GPS), modified GPS (mGPS), prognostic nutritional index (PNI), geriatric nutritional risk index (GNRI), and platelet to lymphocyte ratio (PLR) were calculated from the blood test results. In the infectious group, the white blood cell count, platelet count, CRP level, erythrocyte sedimentation rate, CAR, GPS, mGPS, and PLR were significantly higher, while the albumin level, AGR, PNI, and GNRI were significantly lower. The CRP and albumin levels showed the highest sensitivity (1.00 for both; specificity of 0.87 and 0.73, respectively) in diagnosing infectious RHD. Combining these measurements (CAR) increased the specificity to 0.92. The accuracy of other nutritional assessments was good. Thus, nutritional assessment as well as conventional assessment of the inflammatory response can improve the accuracy of preoperative diagnosis of infectious RHD.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35246574 PMCID: PMC8897466 DOI: 10.1038/s41598-022-07678-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Study flowchart of all cases.
Figure 2Diagnostic flowchart. CRP C-reactive protein, ESR Erythrocyte sedimentation rate, HPF High-powered field, MSIS Musculoskeletal Infection Society, ONFH Osteonecrosis of the femoral head, RDC Rapidly destructive coxarthrosis, RHD Rapid hip destruction. †Ref. 32; ‡Ref. 38.
Patient demographic data.
| Demographic data | All patients (n = 50) | Patients with infectious RHD (n = 13) | Patients with non-infectious RHD (n = 37) | |
|---|---|---|---|---|
| Patient age, years (IQR) | 65 (56–74) | 61 (51–71) | 65 (57–75) | 0.868* |
| Female patients, n (%) | 29 (58) | 6 (46) | 23 (62) | 0.346† |
| BMI, kg/m2 (IQR) | 23.0 (20.4–26.3) | 23.5 (22.0–26.4) | 22.8 (20.3–25.6) | 0.413* |
| Time until femoral head destruction, months (IQR) | 4 (2.5–6) | 3 (2.5–6) | 4 (2.75–6) | 0.751* |
| Time from the first onset to surgery, months (IQR) | 7 (3–10) | 7.0 (3–9) | 6.5 (3–12) | 0.577* |
| Harris hip score, points (IQR) | 43 (26–54) | 32 (24–54) | 44 (30–54) | 0.617* |
| Diabetes mellitus, n (%) | 23 (46) | 4 (31) | 20 (54) | 0.202†§ |
| Hemodialysis, n (%) | 5 (10.0) | 1 (7.7) | 4 (10.8) | 1.000† |
| Use of steroids, n (%) | 15 (30) | 3 (23) | 12 (32) | 0.728† |
| Use of antibiotics, n (%) | 12 (24) | 8 (62) | 4 (11) | < 0.001†§ |
BMI Body mass index, IQR Interquartile range, RHD Rapid hip destruction.
*Mann–Whitney’s U test.
†Fisher’s exact test.
§Statistically significant.
Patients laboratory data.
| Laboratory data | All patients (n = 50) | Patients with infectious RHD (n = 13) | Patients with non-infectious RHD (n = 37) | |
|---|---|---|---|---|
WBC count, 10*3/μL (IQR) Total patients | 6.8 (5.9–8.1) | 7.9 (6.3–10.5) | 6.5 (5.7–7.5) | 0.044*§ |
Steroids user No user | 8.0 (6.3–10.6) 6.4 (5.9–7.5) | 10.5(9.2–10.6) 7.4 (6.1–8.3) | 7.4 (5.9–9.3) 6.3 (5.7–7.2) | N.S |
| Lymphocyte count, 10*3/μL (IQR) | 1.2 (0.9–1.5) | 1.3 (0.9–1.5) | 1.2 (0.9–1.5) | 0.868* |
| Neutrophil count, 10*3/μL (IQR) | 4.9 (3.6–6.3) | 5.9 (5.1–7.3) | 4.6 (3.4–5.6) | 0.032*§ |
| Monocyte count, 10*2/μL (IQR) | 4.9 (3.5–6.2) | 5.8 (4.2–6.8) | 4.5 (3.5–5.8) | 0.284* |
| Platelet count, 10*4/μL (IQR) | 25.7 (20.0–33.8) | 45.7 (33.0–49.8) | 21.4 (18.2–29.3) | < 0.001*§ |
| CRP, mg/L (IQR) | 6.6 (1.1–22.7) | 56.4 (48.2–96.9) | 2.5 (0.7–8.2) | < 0.001*§ |
| ESR, mm/h (IQR) | 19 (9–49) | 76 (58–100) | 13 (6–22) | < 0.001*§ |
| HbA1c, % (IQR) | 5.7 (5.3–6.2) | 5.8 (5.3–6.5) | 5.7 (5.4–6.1) | 0.835* |
| Total protein, g/dL (IQR) | 7.0 (5.1–8.3) | 7.1 (5.1–8.3) | 6.9 (5.7–8.2) | 0.73|| |
| Albumin, g/dL (IQR) | 4.0 (3.5–4.2) | 3.1 (2.7–3.6) | 4.1 (3.9–4.3) | < 0.001*§ |
CRP C-reactive protein, ESR Erythrocyte sedimentation rate, HbA1c Glycated hemoglobin A1c, IQR Interquartile range, RHD Rapid hip destruction, WBC White blood cell.
*Mann–Whitney’s U test.
||Welch’s T-test.
§Statistically significant.
Patient laboratory, inflammation and nutrition data.
| Inflammation and nutrition data | All patients (n = 50) | Patients with infectious RHD (n = 13) | Patients with non-infectious RHD (n = 37) | |
|---|---|---|---|---|
| AGR (IQR) | 1.4 (1.0–1.5) | 0.8 (0.7–1.0) | 1.4 (1.3–1.6) | < 0.001*§ |
| CAR (IQR) | 1.72 (0.26–5.74) | 18.2 (13.4–34.6) | 0.68 (0.16–2.00) | < 0.001*§ |
| GPS, points (IQR) | 0 (0–2) | 2 (1–2) | 0 (0–0) | < 0.001*§ |
| mGPS, points (IQR) | 1 (0–2) | 2 (1–2) | 0 (0–1) | < 0.001*§ |
| PNI (IQR) | 45.4 (40.4–49.0) | 37.1 (33.7–44.4) | 48.2 (44.0–49.3) | < 0.001*§ |
| GNRI (IQR) | 102.6 (96.1–107.1) | 91.0 (82.8–101.4) | 104.1 (101.3–110.3) | 0.001*§ |
| NLR (IQR) | 3.80 (2.71–5.54) | 4.46 (3.44–10.8) | 3.80 (2.44–5.31) | 0.199* |
| PLR (IQR) | 23.0 (15.7–32.7) | 34.7 (26.8–50.6) | 18.7 (13.7–29.3) | 0.006*§ |
| LMR (IQR) | 2.70 (2.05–3.82) | 2.23 (1.84–3.52) | 2.72 (2.22–3.89) | 0.303* |
AGR Albumin/globulin ratio, CAR CRP-albumin ratio, GNRI Geriatric nutritional risk index, GPS Glasgow prognostic score, IQR Interquartile range, LMR Lymphocyte/monocyte ratio, mGPS Modified Glasgow prognostic score, NLR Neutrophil/lymphocyte ratio, PLR Platelet/lymphocyte ratio, PNI Prognostic nutrition index, RHD Rapid hip destruction.
*Mann–Whitney’s U test.
§Statistically significant.
Patient radiographical data.
| Radiographical data | All patients (n = 50) | Patients with infectious RHD (n = 13) | Patients with non-infectious RHD (n = 37) | |
|---|---|---|---|---|
| Degree of femoral head destruction, % (IQR) | 33 (20–47) | 39 (17–58) | 31 (21–47) | 0.799* |
| Acetabular destruction, n (%) | 25 (50.0) | 7 (53.8) | 18 (48.6) | 1.000† |
| Bone marrow edema of the femoral head, n (%) | 48 (96.0) | 13 (100) | 35 (94.6) | 1.000† |
| Bone marrow edema of the acetabulum, n (%) | 33 (66.0) | 11 (84.6) | 22 (59.5) | 0.173† |
| Abscess, n (%) | 2 (4.0) | 2 (15.4) | 0 (0) | 0.064† |
| High signals of the hip joint surrounding muscles, n (%) | 19 (38.0) | 10 (76.9) | 9 (24.3) | 0.002†§ |
IQR Interquartile range, RHD Rapid hip destruction.
*Mann–Whitney’s U test.
†Fisher’s exact test.
§Statistically significant.
Patients tissue microbiological culture and histopathology data.
| Tissue microbiological culture and histopathology data | All patients (n = 50) | Patients with infectious RHD (n = 13) | Patients with non-infectious RHD (n = 37) | |
|---|---|---|---|---|
| Dry tap, n (%) | 16 (32.0) | 1 (7.7) | 15 (40.5) | 0.0391†§ |
| Culture positive, n (%) | 10 (20.0) | 10 (76.9) | 0 (0) | < 0.001†§ |
| Culture positive, n (%) | 3 (6.0) | 3 (23.1) | 0 (0) | 0.0146†§ |
| Neutrophilic infiltration > 5/HPF, n (%) | 14 (28.0) | 10 (76.9) | 4 (10.1) | < 0.001†§ |
| Neutrophilic infiltration > 10/HPF, n (%) | 7 (14.0) | 7 (61.5) | 0 (0) | < 0.001†§ |
HPF High-powered field, IQR Interquartile range, PAC Preoperative joint aspiration culture, RHD Rapid hip destruction.
†Fisher’s exact test.
§Statistically significant.
Diagnostic accuracy of the tests of infection.
| Index | Accuracy (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
|---|---|---|---|---|---|
| MRI: inflammatory spread to soft tissues surrounding hip joints | 0.76 (0.62–0.87) | 0.77 (0.46–0.95) | 0.76 (0.59–0.88) | 0.53 (0.29–0.76) | 0.90 (0.74–0.98) |
| PAC: positive | 0.94 (0.84–0.99) | 0.77 (0.46–0.95) | 1.00 (0.86–1.00) | 1.00 (0.59–1.00) | 0.93 (0.80–0.98) |
| Neutrophilic infiltration > 5/HPF | 0.86 (0.73–0.94) | 0.77 (0.46–0.95) | 0.89 (0.75–0.97) | 0.71 (0.42–0.92) | 0.92 (0.78–0.98) |
| Neutrophilic infiltration > 10/HPF | 0.88 (0.76–0.96) | 0.54 (0.25–0.81) | 1.00 (0.86–1.00) | 1.00 (0.47–1.00) | 0.86 (0.72–0.95) |
CI Confidence interval, MRI Magnetic resonance imaging, NPV Negative predictive value, PAC Preoperative joint aspiration culture, PPV Positive predictive value, WBC White blood cell.
Diagnostic accuracy of the markers of infection.
| Index | Cut-off | AUC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
|---|---|---|---|---|---|---|
| CRP, mg/L | > 10 | 0.99 (0.97–1.00) | 1.00 (0.66–1.00) | 0.87 (0.71–0.96) | 0.72 (0.47–0.90) | 1.00 (0.84–1.00) |
| ESR, mm/h | > 30 | 0.95 (0.90–1.00) | 0.85 (0.55–0.98) | 0.84 (0.68–0.94) | 0.65 (0.38–0.86) | 0.94 (0.80–0.99) |
| WBC count, 10*3/μL | > 7.3 | 0.69 (0.53–0.86) | 0.69 (0.39–0.91) | 0.68 (0.50–0.82) | 0.43 (0.22–0.66) | 0.86 (0.68–0.96) |
| Platelet count, 10*4/μL | > 3.3 | 0.86 (0.73–0.99) | 0.77 (0.46–0.95) | 0.84 (0.68–0.94) | 0.63 (0.35–0.85) | 0.91 (0.76–0.98) |
| Albumin, g/dL | < 4.0 | 0.93 (0.86–1.00) | 1.00 (0.66–1.00) | 0.73 (0.56–0.86) | 0.57 (0.35–0.77) | 1.00 (0.82–1.00) |
| AGR | < 1.1 | 0.96 (0.91–1.00) | 0.92 (0.64–1.00) | 0.95 (0.82–0.99) | 0.86 (0.57–0.98) | 0.97 (0.86–1.00) |
| CAR | > 4.56 | 0.99 (0.97–1.00) | 1.00 (0.66–1.00) | 0.92 (0.78–0.98) | 0.81 (0.54–0.96) | 1.00 (0.85–1.00) |
| GPS, points | > 0 | 0.97 (0.94–1.00) | 1.00 (0.66–1.00) | 0.81 (0.65–0.92) | 0.65 (0.41–0.85) | 1.00 (0.83–1.00) |
| mGPS, points | > 1 | 0.92 (0.85–0.99) | 0.69 (0.39–0.91) | 0.95 (0.82–0.99) | 0.82 (0.48–0.98) | 0.90 (0.76–0.96) |
| PNI | < 46.4 | 0.87 (0.77–0.97) | 1.00 (0.66–1.00) | 0.62 (0.44–0.78) | 0.50 (0.30–0.70) | 1.00 (0.77–1.00) |
| GNRI | < 98 | 0.81 (0.65–0.97) | 0.69 (0.39–0.91) | 0.81 (0.65–0.92) | 0.56 (0.30–0.80) | 0.88 (0.73–0.97 |
| PLR | > 34.7 | 0.76 (0.58–0.94) | 0.54 (0.25–0.81)) | 0.94 (0.80–0.99) | 0.78 (0.40–0.97) | 0.84 (0.69–0.94) |
AGR Albumin/globulin ratio, AUC Area under the curve, CAR CRP-albumin ratio, CI Confidence interval, CRP C-reactive protein, ESR Erythrocyte sedimentation rate, GNRI Geriatric nutritional risk index, GPS Glasgow prognostic score, mGPS Modified Glasgow prognostic score, NPV Negative predictive value, PLR Platelet/lymphocyte ratio, PNI Prognostic nutrition index, PPV Positive predictive value, WBC White blood cell.